What is the appropriate management for a pediatric patient with status asthmaticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pediatric Status Asthmaticus

Immediately administer high-flow oxygen via face mask to maintain oxygen saturation >92%, nebulized salbutamol 5 mg (or 2.5 mg if age ≤2 years) every 20 minutes for up to 3 doses, systemic corticosteroids (oral prednisolone 1-2 mg/kg or IV hydrocortisone if unable to take oral), and add ipratropium 100 mcg to the nebulizer for moderate to severe exacerbations. 1, 2

Recognition of Severity

Identify children requiring immediate aggressive intervention by assessing for:

Severe exacerbation features: 1, 2

  • Too breathless to talk or feed
  • Respiratory rate >50 breaths/minute
  • Pulse >140 beats/minute
  • Peak expiratory flow <50% predicted
  • Use of accessory muscles

Life-threatening features requiring escalation: 3, 1

  • Peak flow <33% predicted or poor respiratory effort
  • Silent chest, cyanosis, or exhaustion
  • Altered level of consciousness or agitation
  • Oxygen saturation <92% despite supplemental oxygen

Immediate Treatment Protocol

First-Line Therapy (Administer Simultaneously)

Oxygen: 1, 2

  • High-flow oxygen via face mask immediately
  • Maintain oxygen saturation >92% throughout treatment
  • Continue pulse oximetry monitoring

Beta-Agonist Bronchodilator: 1, 4

  • Salbutamol 5 mg via oxygen-driven nebulizer (2.5 mg if age ≤2 years)
  • Alternative: 4-8 puffs via MDI with large volume spacer
  • Repeat every 20 minutes for up to 3 doses in the first hour
  • MDI with spacer is equally effective to nebulization and may result in lower admission rates with fewer cardiovascular side effects 1, 2

Systemic Corticosteroids (Do NOT Delay): 1, 2

  • Oral route preferred: Prednisolone 1-2 mg/kg daily (maximum 60 mg) if child can swallow and is not vomiting 1, 4
  • IV route: Hydrocortisone 200 mg every 6 hours (or 4 mg/kg/dose every 6 hours) if vomiting, seriously ill, or unable to take oral medications 2
  • Administer within the first hour—underuse of corticosteroids is a leading cause of preventable asthma mortality 2

Ipratropium Bromide: 1, 2

  • Add ipratropium 100 mcg to nebulizer immediately for moderate to severe exacerbations
  • Repeat every 6 hours until improvement starts
  • Particularly indicated when initial beta-agonist treatment fails 2

Life-Threatening Features Present

If life-threatening features are identified: 3, 2

  • Give IV aminophylline 5 mg/kg over 20 minutes followed by maintenance infusion 1 mg/kg/hour
  • Omit loading dose if child already receiving oral theophyllines
  • Consider IV magnesium sulfate for life-threatening exacerbations or those remaining severe after 1 hour of intensive conventional treatment 2

Reassessment and Monitoring

Repeat assessment 15-30 minutes after starting treatment: 1, 2

  • Measure peak expiratory flow before and after each bronchodilator dose
  • Chart PEF at least 4 times daily throughout hospital stay
  • Maintain continuous pulse oximetry with target >92%
  • Response to treatment in the ED is a better predictor of hospitalization need than initial severity 2

Subsequent Management Based on Response

If Patient is Improving: 3, 1

  • Continue high-flow oxygen
  • Continue prednisolone 1-2 mg/kg daily (maximum 40-60 mg)
  • Continue nebulized β-agonist 4 hourly

If Patient is NOT Improving After 15-30 Minutes: 3, 1

  • Continue oxygen and steroids
  • Increase nebulized β-agonist frequency up to every 30 minutes
  • Ensure ipratropium is added to nebulizer and repeat 6 hourly
  • Consider escalation to second-line therapies

Critical Pitfalls to Avoid

Do NOT delay systemic corticosteroids while giving repeated albuterol doses alone—this is a common cause of treatment failure and preventable mortality. 1, 2

Do NOT use sedatives of any kind in acute severe asthma, as they can depress respiratory function. 1, 2

Do NOT use antibiotics routinely unless bacterial infection is confirmed—viral respiratory infections are the most common trigger in this age group. 2

Do NOT delay intubation once deemed necessary—signs of impending respiratory failure include inability to speak, altered mental status, worsening fatigue, and PaCO₂ ≥42 mm Hg. 2, 5

Hospital Admission Criteria

Admit to hospital if: 1, 2

  • Persistent features of severe asthma after initial treatment
  • Peak expiratory flow remaining <50% predicted 15-30 minutes after treatment
  • Life-threatening features present
  • Parents unable to give appropriate treatment at home

Transfer to Intensive Care Unit

Transfer to ICU accompanied by a doctor prepared to intubate if: 3, 1

  • Deteriorating peak flow or worsening exhaustion
  • Persistent hypoxemia or hypercapnia despite treatment
  • Feeble respirations or poor respiratory effort
  • Altered consciousness, confusion, or drowsiness
  • Coma or respiratory arrest

Discharge Criteria

Children can be discharged when: 3, 1

  • On discharge medication for 24 hours with inhaler technique checked and recorded
  • PEF >75% of predicted or best with diurnal variability <25%
  • Treatment includes oral steroids (continue for 3-5 days) and inhaled steroids in addition to bronchodilators 2, 4
  • Written asthma action plan provided to parents 4
  • GP follow-up arranged within 1 week
  • Respiratory clinic follow-up within 4 weeks

References

Guideline

Management of Moderate to Severe Acute Asthma Exacerbation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Exacerbation Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical review: severe asthma.

Critical care (London, England), 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.